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According to the modern understanding of cancer, it is a disease that is primarily
associated with genetic and epigenetic alterations.
1 Numerous studies, including
our earlier works, have supported the notion that carcinogenesis involves the
activation of tumor-promoting oncogenes and the inactivation of growth-inhibiting
tumor suppressor genes. However, extensive research is warranted in two areas,
namely, tumor bioenergetics and the cancer stem cell (CSC) hypothesis, which
did not receive the required attention after the success of the genome sequencing
project ofthe 21st century. An investigation of these two concepts would give rise
to a new era in the study of cancer biology. Indeed, recent studies have indicated
that the two apparently distinct fields might be related to each other and can
converge more rapidly than previously recognized. 
The Warburg effect
Otto Warburg won a Nobel Prize in 1931 for his work on respiratory impairment
in cancer. Warburg showed that unlike normal tissues that derive most of their
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Although the notion that cancer is a disease caused by genetic and epigenetic
alterations is now widely accepted, perhaps more emphasis has been given to the
fact that cancer is a genetic disease. It should be noted that in the post-genome
sequencing project period of the 21st century, the underlined phenomenon
nevertheless could not be discarded towards the complete control of cancer
disaster as the whole strategy, and in depth investigation of the factors associated
with tumorigenesis is required for achieving it. Otto Warburg has won a Nobel
Prize in 1931 for the discovery of tumor bioenergetics, which is now commonly
used as the basis of positron emission tomography (PET), a highly sensitive
noninvasive technique used in cancer diagnosis. Furthermore, the importance of
the cancer stem cell (CSC) hypothesis in therapy-related resistance and metastasis
has been recognized during the past 2 decades. Accumulating evidence suggests
that tumor bioenergetics plays a critical role in CSC regulation; this finding has
opened up a new era of cancer medicine, which goes beyond cancer genomics.
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INTRODUCTION
TUMOR BIOENERGETICSATP by metabolizing glucose to carbon dioxide and water,
which is an oxygen-dependent process performed by the
mitochondria, cancer cells rarely depend on mitochondria
for respiration and obtain almost half of their ATP by
directly metabolizing glucose to lactic acid, even in the pre-
sence of oxygen.
2 However, with the discovery that tumors
do not show any shift to glycolysis,
3 Warburg’s cancer
theory (high lactate production and low mitochondrial res-
piration in tumor under normal oxygen pressure) was gradu-
ally discredited. The ascendancy of molecular biology over
the last quarter of the century has placed more emphasis on
the genetic alterations of cancer cells, and eclipsed the
study of tumor bioenergetics, including Warburg’s ideas. 
Significance of the Warburg effect
The increasing number of recent reports on the Warburg
effect has reestablished the significance of this effect in
tumorigenesis, indicating that bioenergetics may play a
critical role in malignant transformation. Furthermore, it
has been reported that TP53, which is one of the most com-
monly mutated genes in cancer, can trigger the Warburg
effect.
4 Glycolytic conversion is initiated in the early stages
in cells that are genetically engineered to become cancer-
ous, and the conversion was enhanced as the cells became
more malignant.
5 Therefore, the Warburg effect might direc-
tly contribute to the initiation of cancer formation not only
by enhanced glycolysis but also via decreased respiration
in the presence of oxygen, which suppresses apoptosis.
6 This
effect may also produce a metabolic shift to enhanced gly-
colysis and play a role in the early stages of multistep tumo-
rigenesis in vivo.
7 
Embryonic stem (ES) cells and immortalized primary
and cancerous cells show the common concerted metabolic
shift, including enhanced glycolysis, decreased apoptosis,
and reduced mitochondrial respiration; however, the me-
chanism underlying this shift is poorly characterized.
7 This
finding reinforces the use of somatic stem cells or metas-
tatic tumor cells in hypoxic niches. Hypoxia appears to
regulate the functions of hematopoietic stem cells in the
bone marrow
8 and metastatic tumor cells (M. Mori, unpu-
blished data) by preserving important stem cell functions,
such as cell cycle control, survival, metabolism, and pro-
tection against oxidative stress.
However, this idea is still a controversial topic;
3 one of
the arguments suggest that the Warburg effect is the
consequence of cancer, and not the main contributing factor
of the disease. Nevertheless, several companies and labora-
tories, including ours, are now attempting to evaluate the
bioenergetics associated with tumorigenesis by testing and
challenging the available anticancer drugs. 
The Warburg effect is now the basis for positron emission
tomography (PET), a highly sensitive noninvasive techni-
que used in pre-clinical and clinical imaging of cancer
biology; this technique has facilitated early diagnosis and
better management of oncology patients.
9 With greater
acceptance, it should become an increasingly important
technique for cancer imaging in the next decade.
9
The hypothesis
In 1937, Furth and Kahn
10 showed that leukemia can be
initiated in mice using a single tumorigenic cell. This gave
rise to a notion that a single or a few malignant cells,
which have been transformed from normal somatic cells,
can produce tumors. During the turn of the 21st century,
the CSC hypothesis has gained recognition again, mainly
in the Western world. After the identification of rare
CSCs in leukemia,
11-13 molecular markers for detecting
CSCs in solid tumors, such as head and neck,
14 breast,
15
and brain cancers,
16,17 have also been identified. The re-
search team at one of our laboratories has obtained the
first evidence of CSCs in the gastrointestinal system,
18 and
our findings have subsequently been confirmed by other
researchers.
19,20 
Significance of the hypothesis
A small population of cancer-initiating cells plays a very
important role, in that it may cause resistance to chemothe-
rapy or radiation therapy or lead to post-therapy recurrence
even when most of the cancer cells appear to be dead.
21 In
addition to their genetic alterations, CSCs are believed to
mimic normal adult stem cells with regard to properties
like self renewal and undifferentiated status, which eventu-
ally leads to the formation of differentiated cells.
22 More-
over, unlike well-differentiated daughter cells, small popula-
tions of CSCs are believed to be more resistant to toxic
injuries and chemoradiotherapy.
23 Whereas the conventional
cancer therapies have always been targeted toward proli-
ferating cells, the control of CSCs, which is often exercised
in the dormant phase of the cell cycle, can now be applied
to achieve complete tumor regression. 
Identification of cancer-specific markers
Due to their potential use in clinical applications, the surface
markers of CSCs have been studied and identified. Adult
stem cells and their malignant counterparts share similar
intrinsic and extrinsic factors that regulate the self renewal,
differentiation, and proliferation pathways.
24 The following
are the examples of candidate markers: musashi-1 (Msi-1),
25
hairy and enhancer of split homolog-1 (Hes-1),
26 CD133
(prominin-1, Prom1),
27,28 epithelial cellular adhesion mole-
cule (EpCam),
29 claudin-7,
29 CD44 variant isoforms,
29 Lgr5,
30
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Hedgehog (Hh),
31 bone morphogenic protein (Bmp),
32,33
Notch,
34 and Wnt.
35 Nevertheless, little is known about the
molecular markers that are characteristic of dormant stem
cells and amplified populations of differentiating cells of
solid tumors, such as the tumors of the gastrointestinal
tract.
35
The bioenergetics associated with the adaptation of CSCs
to their microenvironment still requires extensive research.
Although numerous studied suggested the association
between Warburg effect and reduced oxidative stress in
cancer, the relevant molecular mechanism was not known
until very recently when Ruckenstuhl, et al.
6 reported their
findings in a yeast model.
Hypoxic adaptations in the presence of oxygen
Through different biochemical and biophysical pathways,
which are characteristic to cancer cells, tumor cells adopt
this phenotype, i.e., high glycolysis and decreased respira-
tion, in the presence of oxygen. It has been shown that
although the induction of hypoxia and cellular proliferation
engage entirely different cellular pathways, they often
coexist during tumor growth.
36 The ability of cells to grow
during hypoxia results, in part, from the crosstalk between
hypoxia-inducible factors (Hifs) and the proto-oncogene
c-Myc.
36 These genes partially regulate the development of
complex adaptations of tumor cells growing in low O2, and
contribute to fine tuning the adaptive responses of cells to
hypoxic environments.
36 Nevertheless, how cancer cells
achieve one of the most common phenotypes, namely, the
“Warburg effect,” i.e., elevated glycolysis in the presence
of oxygen, is still a topic of hypothesis, unless the involve-
ment of glycolysis genes is considered. 
Recently, it was shown that the hexokinase 2 (Hk-2)
protein, its mitochondrial receptor, namely, voltage-depen-
dent anion channel (Vdac), and the gene encoding Hk-2
play the most pivotal and direct roles in the “Warburg
effect,” despite some impairment in the respiratory capacity
of malignant tumors is involved.
37 Furthermore, metabolic
reprogramming during physiologic cell proliferation and
tumorigenesis may alter cell growth and proliferation by
modifying the flux of cellular mediators of signal transduc-
tion and gene expression, including the expression of
phosphatidylinositol 3-kinase (PI3K)/Akt/mTOR system,
hypoxia-inducible factor 1 (Hif-1), and Myc.
38 In parti-
cular, the genes of many glycolysis enzymes are under the
control of Myc, Hif-1, and tumor suppressor p53,
7 suggest-
ing that enhanced glycolysis is essential for both immor-
talization and transformation, since it renders cells resistant
to oxidative stress and adaptive to hypoxic condition.
7
Low oxidant levels in the niche
A study on hematopoietic stem cells revealed that low
levels of reactive oxygen species are present in the bone
marrow.
39 A low-oxygen niche in the bone marrow limits
reactive oxygen species production, thus providing hema-
topoietic stem cells with a long-term protection from reac-
tive oxygen species stressors such as senescence, apoptosis,
and DNA damage.
39 The research indicated that it is possible
to isolate the early hematopoietic stem cell population by
taking advantage of limited intracellular reactive oxygen
species activity.
39 Thus, somatic stem cells such as those in
the hematopoietic system reside in the hypoxic area in the
bone marrow niche, which affords them protection from
deleterious damages, presumably through the involvement
of glycolytic metabolism.
39,40
The Warburg effect has been observed in differentiating
cancer cells (e.g., cells that undergo epithelial-to-mesen-
chymal and mesenchymal-to-amoeboid transition), cells
resistant to anoikis, and cells which interact with the stromal
components of the metastatic niche.
41 We showed that the
epithelial-to-mesenchymal transition is involved in the
resistance to chemotherapy in gastrointestinal cancer cells.
42
Cancer metastasis can be regarded as an integrated “escape
program” triggered by redox changes.
41 These alterations
might be associated with avoiding oxidative stress in the
niche of the tumor cells, or presumably with the response
to treatments aimed at genetic targets, such as chemothe-
rapy and radiation. Regulation of reactive oxygen species
in CSCs population is an important issue; we are inves-
tigating this topic by in vitro and in vivo experiments. 
We studied the significance of bioenergetics of CSCs.
Although the accomplishments of the genome project have
contributed to cancer research and medicine, we have to
pay more attention inimproving cancer diagnosis and
therapy. In this article, we have highlighted the significance
of a few relevant concepts, which have been recently disco-
vered. Moreover, our study indicated that the introduction
of induced pluripotent stem (iPS) cell genes was necessary
for inducing the expression of immature status-related
proteins in gastrointestinal cancer cells, and that the induced
pluripotent cancer (iPC) cells were distinct from natural
cancer cells with regard to their sensitivity to differentiation-
inducing treatment.
43 For the complete eradication of
cancer, however, future efforts should be directed toward
improving translational research.
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